MicroPort's implantable implantable defibrillator and pacemaker spinoff has secured funding in a series C round co-led by its parent company.
China-headquartered medical device maker MicroPort Scientific Corporation has invested $47m to co-lead a $150m series C round for France-based pacemaker and defibrillator spinoff MicroPort Cardiac Rhythm Management (CRM).
Hedge fund manager Hillhouse Capital Group co-led the round with $26m, and the rest came from property developer Country Garden’s investment arm, Country Garden Venture Capital, as well as China International Capital Corporation, YongRong Asset Management, L Squared Private Management, E Fund Management and Wanhui Capital.
Microport CRM is tasked with commercialising…
